BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19788458)

  • 1. Is it possible to gain extra waiting time to liver transplantation in acute liver failure patients using albumin dialysis?
    Koivusalo AM; Kantola T; Arola J; Höckerstedt K; Kairaluoma P; Isoniemi H
    Ther Apher Dial; 2009 Oct; 13(5):413-8. PubMed ID: 19788458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive criteria for the outcome of patients with acute liver failure treated with the albumin dialysis molecular adsorbent recirculating system.
    Novelli G; Rossi M; Ferretti G; Pugliese F; Ruberto F; Lai Q; Novelli S; Piemonte V; Turchetti L; Morabito V; Annesini MC; Berloco PB
    Ther Apher Dial; 2009 Oct; 13(5):404-12. PubMed ID: 19788457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation avoided in patients with fulminant hepatic failure who received albumin dialysis with the molecular adsorbent recirculating system while on the waiting list: impact of the duration of therapy.
    Camus C; Lavoué S; Gacouin A; Compagnon P; Boudjéma K; Jacquelinet C; Thomas R; Le Tulzo Y
    Ther Apher Dial; 2009 Dec; 13(6):549-55. PubMed ID: 19954480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of albumin dialysis on cytokine levels in acute liver failure and need for liver transplantation.
    Isoniemi H; Koivusalo AM; Repo H; Ilonen I; Höckerstedt K
    Transplant Proc; 2005 Mar; 37(2):1088-90. PubMed ID: 15848631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early molecular adsorbents recirculating system treatment of Amanita mushroom poisoning.
    Kantola T; Kantola T; Koivusalo AM; Höckerstedt K; Isoniemi H
    Ther Apher Dial; 2009 Oct; 13(5):399-403. PubMed ID: 19788456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albumin dialysis and Molecular Adsorbents Recirculating System (MARS) for acute Wilson's disease.
    Sen S; Felldin M; Steiner C; Larsson B; Gillett GT; Olausson M; Williams R; Jalan R
    Liver Transpl; 2002 Oct; 8(10):962-7. PubMed ID: 12360442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine profiles in acute liver failure treated with albumin dialysis.
    Ilonen I; Koivusalo AM; Repo H; Höckerstedt K; Isoniemi H
    Artif Organs; 2008 Jan; 32(1):52-60. PubMed ID: 18181803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure patients.
    Kantola T; Koivusalo AM; Höckerstedt K; Isoniemi H
    Transpl Int; 2008 Sep; 21(9):857-66. PubMed ID: 18510596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of sepsis during MARS treatment in acute on chronic liver failure.
    Novelli G; Morabito V; Pugliese F; Ferretti G; Novelli S; Ianni S; Lai Q; Rossi M; Berloco PB
    Transplant Proc; 2011 May; 43(4):1085-90. PubMed ID: 21620059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albumin dialysis has no clear effect on cytokine levels in patients with life-threatening liver insufficiency.
    Ilonen I; Koivusalo AM; Höckerstedt K; Isoniemi H
    Transplant Proc; 2006 Dec; 38(10):3540-3. PubMed ID: 17175326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial.
    Saliba F; Camus C; Durand F; Mathurin P; Letierce A; Delafosse B; Barange K; Perrigault PF; Belnard M; Ichaï P; Samuel D
    Ann Intern Med; 2013 Oct; 159(8):522-31. PubMed ID: 24126646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive parameters after molecular absorbent recirculating system treatment integrated with model for end stage liver disease model in patients with acute-on-chronic liver failure.
    Novelli G; Rossi M; Ferretti G; Pugliese F; Travaglia D; Guidi S; Novelli S; Lai Q; Morabito V; Berloco PB
    Transplant Proc; 2010 May; 42(4):1182-7. PubMed ID: 20534256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Liver dialysis using MARS in acute hepatic failure. Promising results in a pilot setting].
    Felldin M; Friman S; Olausson M; Bäckman L; Castedal M; Larsson B; Henriksson BA; Siewert-Delle A
    Lakartidningen; 2003 Nov; 100(47):3836-8, 3841. PubMed ID: 14719235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial liver support system in acute liver failure patients waiting liver transplantation.
    Montejo González JC; Catalán González M; Meneu Díaz JC; Moreno Elola-Olaso A; De la Cruz J; Moreno González E
    Hepatogastroenterology; 2009; 56(90):456-61. PubMed ID: 19579620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin dialysis in liver failure: comparison of molecular adsorbent recirculating system and single pass albumin dialysis--a retrospective analysis.
    Kortgen A; Rauchfuss F; Götz M; Settmacher U; Bauer M; Sponholz C
    Ther Apher Dial; 2009 Oct; 13(5):419-25. PubMed ID: 19788459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.
    Bañares R; Nevens F; Larsen FS; Jalan R; Albillos A; Dollinger M; Saliba F; Sauerbruch T; Klammt S; Ockenga J; Pares A; Wendon J; Brünnler T; Kramer L; Mathurin P; de la Mata M; Gasbarrini A; Müllhaupt B; Wilmer A; Laleman W; Eefsen M; Sen S; Zipprich A; Tenorio T; Pavesi M; Schmidt HH; Mitzner S; Williams R; Arroyo V;
    Hepatology; 2013 Mar; 57(3):1153-62. PubMed ID: 23213075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mars and Prometheus: our clinical experience in acute chronic liver failure.
    Faenza S; Baraldi O; Bernardi M; Bolondi L; Coli L; Cucchetti A; Donati G; Gozzetti F; Lauro A; Mancini E; Pinna AD; Piscaglia F; Rasciti L; Ravaioli M; Ruggeri G; Santoro A; Stefoni S
    Transplant Proc; 2008 May; 40(4):1169-71. PubMed ID: 18555140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy.
    Schmidt LE; Tofteng F; Strauss GI; Larsen FS
    Scand J Gastroenterol; 2004 Oct; 39(10):974-80. PubMed ID: 15513337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome from molecular adsorbent recycling system (MARS) liver dialysis following drug-induced liver failure.
    Lee KH; Lee MK; Sutedja DS; Lim SG
    Liver Int; 2005 Oct; 25(5):973-7. PubMed ID: 16162155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience.
    Chiu A; Chan LM; Fan ST
    Liver Int; 2006 Aug; 26(6):695-702. PubMed ID: 16842326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.